A Meta-Analysis of SGLT2 Inhibitors and All-Cause Mortality
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibitors and All-Cause Mortality: A Meta-Analysis of Randomized Controlled Trials
Diabetes Obes Metab 2020 Dec 07;[EPub Ahead of Print], SG Antonio, M Matteo, M EdoardoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.